TRANSLATIONAL RESEARCH ON CANCER EPIGENETICS
The ERA-NET TRANSCAN-3, in continuity of the preceding ERA-NET TRANSCAN-2, has the goal of coordinating national and regional funding programmes for research in the area of translational cancer research. The specific challenge is to promote a transnational collaborative approach between scientific teams in demanding areas of translational cancer research while avoiding the duplication of efforts and ensuring a more efficient use of available resources, to produce significant results of higher quality and impact, and share data and infrastructures.
You can consult the requirements of the call and a summary of the eligibility criteria an outline of eligibility criteria. They will be further detailed when the JTC 2023 is published.
The TRANSCAN-3 JTC 2023 will be implemented through a two-stage submission procedure: pre-proposals and full proposals.
The call is planned to be launched on May 9th 2023 with a submission deadline for pre-proposals in July 2023. It is expected that consortia invited to the full-proposal stage will be asked to submit their proposal in December 2023.
For more information, it is recommended to visit the different links available for this purpose.
Datos de contacto
Ana Moreno: ambofarull(ELIMINAR)@salud.madrid.org / 91 336 9016
Esther Torrecilla: esther.torrecilla(ELIMINAR)@salud.madrid.org / 91 488 9708